Sales rise 21.80% to Rs 789.99 crore
Net profit of Glaxosmithkline Pharmaceuticals rose 9.25% to Rs 121.08 crore in the quarter ended June 2021 as against Rs 110.83 crore during the previous quarter ended June 2020. Sales rose 21.80% to Rs 789.99 crore in the quarter ended June 2021 as against Rs 648.59 crore during the previous quarter ended June 2020. ParticularsQuarter EndedJun. 2021Jun. 2020% Var.Sales789.99648.59 22 OPM %19.2017.59 -PBDT182.61170.91 7 PBT164.90149.14 11 NP121.08110.83 9Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
